127 related articles for article (PubMed ID: 28766544)
1. [EBV-positive central nervous system lymphoproliferative disease associated with immunosuppression after organ transplantation: Long-term remission without chemotherapy].
Gavrilina OA; Troitskaya VV; Zvonkov EE; Parovichnikova EN; Galstyan GM; Biryukova LS; Nesterenko IV; Kovrigina AM; Bazhenov AV; Savchenko VG; Savchenko VG
Ter Arkh; 2017; 89(7):69-75. PubMed ID: 28766544
[TBL] [Abstract][Full Text] [Related]
2. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
Ferguson NN; Thomas CP; Hohl RJ; Syrbu SI; Stone MS; Wanat KA
Am J Dermatopathol; 2015 Oct; 37(10):790-4. PubMed ID: 25747810
[TBL] [Abstract][Full Text] [Related]
3. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
[TBL] [Abstract][Full Text] [Related]
4. Complete resolution of posttransplant lymphoproliferative disorder (diffuse large B-cell lymphoma) with reduction of immunosuppressive therapy.
Ryu HJ; Hahn JS; Kim YS; Park K; Yang WI; Lee JD
Yonsei Med J; 2004 Jun; 45(3):527-32. PubMed ID: 15227742
[TBL] [Abstract][Full Text] [Related]
5. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous Manifestations of Posttransplant Lymphoma in Renal Transplant Recipients: A Case Series.
Patil R; Prashar R; Patel A
Transplant Proc; 2021 Jun; 53(5):1519-1527. PubMed ID: 34134932
[TBL] [Abstract][Full Text] [Related]
7. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
[TBL] [Abstract][Full Text] [Related]
8. Conservative management of post-transplant central nervous system lymphoma.
Valavoor SH; Ashraf Z; Narwal R; Ratnam S
Int Urol Nephrol; 2013 Aug; 45(4):1219-22. PubMed ID: 22476860
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
Leblond V; Davi F; Charlotte F; Dorent R; Bitker MO; Sutton L; Gandjbakhch I; Binet JL; Raphael M
J Clin Oncol; 1998 Jun; 16(6):2052-9. PubMed ID: 9626203
[TBL] [Abstract][Full Text] [Related]
10. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
Banks CA; Meier JD; Stallworth CR; White DR
Ann Otol Rhinol Laryngol; 2012 May; 121(5):291-5. PubMed ID: 22724273
[TBL] [Abstract][Full Text] [Related]
11. Posttransplant lymphoproliferative disorder of the nasopharynx.
Vargas H; Nazeer T; Conti D; Parnes SM
Am J Rhinol; 2002; 16(1):37-42. PubMed ID: 11895192
[TBL] [Abstract][Full Text] [Related]
12. Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation.
Twombley K; Pokala H; Ardura MI; Harker-Murray P; Johnson-Welch SF; Weinberg A; Seikaly M
Pediatr Transplant; 2012 Sep; 16(6):E201-9. PubMed ID: 22646132
[TBL] [Abstract][Full Text] [Related]
13. Quiz page. Posttransplantation lymphoproliferative disorder (PTLD) involving the brain and the allograft.
Tang S; Lai KN
Am J Kidney Dis; 2005 Apr; 45(4):A55, e61-2. PubMed ID: 15806458
[No Abstract] [Full Text] [Related]
14. Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.
Arita H; Izumoto S; Kinoshita M; Okita Y; Hashimoto N; Fujita T; Ichimaru N; Takahara S; Yoshimine T
Neurol Med Chir (Tokyo); 2010; 50(12):1079-83. PubMed ID: 21206182
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
Taylor AL; Marcus R; Bradley JA
Crit Rev Oncol Hematol; 2005 Oct; 56(1):155-67. PubMed ID: 15979320
[TBL] [Abstract][Full Text] [Related]
16. [Cutaneous non-Hodgkin lymphoma of the leg occurring 11 years after renal transplantation].
Kudo K; Sonoda M; Sugimoto K; Koike M
Rinsho Ketsueki; 2009 Feb; 50(2):107-9. PubMed ID: 19265304
[TBL] [Abstract][Full Text] [Related]
17. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
[TBL] [Abstract][Full Text] [Related]
18. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?
Gibson SE; Swerdlow SH; Craig FE; Surti U; Cook JR; Nalesnik MA; Lowe C; Wood KM; Bacon CM
Am J Surg Pathol; 2011 Jun; 35(6):807-15. PubMed ID: 21552113
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B
Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
[TBL] [Abstract][Full Text] [Related]
20. A case of Epstein-Barr virus associated post-transplant lymphoproliferative disorder with CNS involvement: pathological findings at both biopsy and autopsy.
Suzuki M; Kosugi I; Terada T; Shirakawa K; Suzuki H; Kono S; Miyajima H
Neuropathology; 2011 Aug; 31(4):440-5. PubMed ID: 21134001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
